In a possible first in Japan, doctors have used artificial intelligence to diagnose a rare type of leukemia and identify life-saving therapy far faster than if they had examined the genetic data manually.

According to Arinobu Tojo, professor of molecular therapy at a hospital affiliated to the University of Tokyo's Institute of Medical Science, a female patient in her 60s admitted in January 2015 was initially diagnosed with acute myeloid leukemia, a blood cancer characterized by rapid growth of abnormal white blood cells.

She underwent chemotherapy at the hospital, which successfully attacked the cancer cells.